Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Hancock Whitney
HWC
$6.21B
| $18.7M | 0.02% |
466,750
-3,500
| -0.7% | -$144K |
|
1002
Hexcel
HXL
$8.05B
| $18.7M | 0.02% |
230,700
+96,000
| +71% | +$6.98M |
|
1003
NiSource
NI
$21.5B
| $18.6M | 0.02% |
647,200
+464,600
| +254% | +$13.1M |
|
|
SP
1004
DELISTED
SP Plus Corporation
SP
| $18.6M | 0.02% |
583,700
+49,489
| +9% | +$1.63M |
|
|
RCM
1005
DELISTED
R1 RCM Inc. Common Stock
RCM
| $18.6M | 0.02% |
1,477,146
-1,135,022
| -43% | -$12.8M |
|
1006
Barclays
BCS
$89B
| $18.5M | 0.02% |
2,487,801
+1,423,920
| +134% | +$11.2M |
|
|
CTWS
1007
DELISTED
Connecticut Water Service Inc
CTWS
| $18.5M | 0.02% |
265,400
+17,200
| +7% | +$1.19M |
|
1008
Autodesk
ADSK
$51.9B
| $18.5M | 0.02% |
113,368
-174,900
| -61% | -$29.4M |
|
1009
Urban Edge Properties
UE
$2.91B
| $18.4M | 0.02% |
1,063,300
+138,100
| +15% | +$2.52M |
|
1010
Hackett Group
HCKT
$284M
| $18.4M | 0.02% |
1,094,244
+38,800
| +4% | +$626K |
|
|
DHIL
1011
DELISTED
Diamond Hill
DHIL
| $18.4M | 0.02% |
129,486
+7,753
| +6% | +$1.11M |
|
|
CWEN.A
1012
DELISTED
Clearway Energy Class A
CWEN.A
| $18.3M | 0.02% |
1,131,676
+51,876
| +5% | +$786K |
|
1013
Schneider National
SNDR
$6.2B
| $18.3M | 0.02% |
1,003,600
+281,700
| +39% | +$5.46M |
|
1014
Descartes Systems
DSGX
$6.73B
| $18.3M | 0.02% |
494,800
-21,300
| -4% | -$829K |
|
1015
Preferred Bank
PFBC
$1.24B
| $18.2M | 0.02% |
384,455
+9,200
| +2% | +$432K |
|
1016
Sun Life Financial
SLF
$45.8B
| $18.1M | 0.02% |
438,500
+145,900
| +50% | +$5.86M |
|
1017
Stoneridge
SRI
$200M
| $18.1M | 0.02% |
572,919
-54,400
| -9% | -$1.61M |
|
1018
TTEC Holdings
TTEC
$123M
| $18.1M | 0.02% |
387,900
+4,800
| +1% | +$185K |
|
|
LPT
1019
DELISTED
Liberty Property Trust
LPT
| $18.1M | 0.02% |
361,000
+154,100
| +74% | +$7.54M |
|
|
CMO
1020
DELISTED
Capstead Mortgage Corp.
CMO
| $18.1M | 0.02% |
2,162,900
+33,900
| +2% | +$285K |
|
1021
Warrior Met Coal
HCC
$4.19B
| $18.1M | 0.02% |
691,300
+531,600
| +333% | +$15.1M |
|
1022
Boeing
BA
$172B
| $18.1M | 0.02% |
49,600
-180,600
| -78% | -$65.9M |
|
1023
Anika Therapeutics
ANIK
$220M
| $18M | 0.02% |
444,222
+78,812
| +22% | +$2.87M |
|
|
QVCGA
1024
DELISTED
QVC Group Inc Series A
QVCGA
| $18M | 0.02% |
29,999
+16,212
| +118% | +$11.6M |
|
1025
United States Lime & Minerals
USLM
$3.24B
| $18M | 0.02% |
1,126,300
+4,575
| +0.4% | +$74K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.